WASHINGTON, Feb. 4 -- Sen. Richard Blumenthal issued text of the following press release: In case you missed it, U.S. Senator Richard Blumenthal (D-CT), Ranking Member of the Permanent Subcommittee o... Read More
WASHINGTON, Feb. 4 -- Sen. Richard Blumenthal issued text of the following press release: U.S. Senator Richard Blumenthal (D-CT), Ranking Member of the Permanent Subcommittee on Investigations (PSI),... Read More
Washington, Feb. 4 -- Congresswoman Sarah Elfreth issued the following press release: Yesterday, Congresswoman Sarah Elfreth (MD-03) spoke on the House floor during a Special Order Hour organized by ... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (NCT07388537) titled 'Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adult... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (NCT07388524) titled 'Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prev... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (NCT07388563) titled 'Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma' on Feb. 4... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (NCT07388550) titled 'Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute ... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ACTRN12626000141347) titled 'Critical Illness, Infection and Immunology Biobank' on Feb. 4. Study ... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ACTRN12626000136303) titled 'Gabi the therapist supervised chatbot coach for problem gambling' on F... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ACTRN12626000140358) titled 'Testing a new digital platform (ReMedi) to help people report and mana... Read More